Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Lonza, Sunshine Enter Manufacturing Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News

Lonza, Sunshine Enter Manufacturing Pact

Lonza to manufacture anti-cancer drug at Nansha and Visp facilities

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Sunshine Biopharma Inc. has entered an agreement with Lonza for the manufacture of its anti-cancer drug, Adva-27a. Lonza will begin manufacturing at its Nansha, China facility with the remaining key steps to be carried out at its high containment cytotoxic facility in Visp, Switzerland. 
 
“We are delighted to have a global leader like Lonza as our manufacturing partner,” said Dr. Steve N. Slilaty, president and chief executive officer of Sunshine Biopharma. “We have made significant recent strides in terms of research results showing the effectiveness of our lead compound against cancer cells as well as in our manufacturing and recent fund raising efforts.”
 
“We are very excited to be working with Sunshine Biopharma on the development of their promising anti-cancer compound,” said James Leresche, Ph.D., head of Lonza’s Chemical Development Services. “This development project is an example of Lonza’s support and commitment to emerging companies with innovative and potentially life-saving treatments like Adva-27a.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics